Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Spinocerebellar Ataxia Type 6: later-stage trial registry
1 of 4 indexed Spinocerebellar Ataxia Type 6 trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Spinocerebellar Ataxia Type 6: 4 US clinical trials tracked, 1 recruiting.
Spinocerebellar Ataxia Type 6 is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Biohaven Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition spinocerebellar-ataxia-type-6
OPEN 1 | RECR 25% | LATE 2 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Spinocerebellar Ataxia Type 6 lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Spinocerebellar Ataxia Type 6 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Spinocerebellar Ataxia Type 6 is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Deep Brain Stimulation for Spinocerebellar Ataxia
University of California, San Francisco
NCT07288437
Troriluzole in Adult Participants With Spinocerebellar Ataxia
Biohaven Pharmaceuticals
NCT03701399
Open Pilot Trial of BHV-4157
University of California, Los Angeles
NCT03408080
Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia
Teachers College, Columbia University
NCT05826171
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Spinocerebellar Ataxia Type 6 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Spinocerebellar Ataxia Type 6 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Spinocerebellar Ataxia Type 6 page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Spinocerebellar Ataxia Type 6 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Biohaven Pharmaceuticals sponsors the most Spinocerebellar Ataxia Type 6 trials on record, review their full trial history before evaluating a specific study. See Biohaven Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Spinocerebellar Ataxia Type 6 condition card totals 4 registered trials; most-linked intervention troriluzole; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.